Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation

Brahma Ghosh, Alexey Benyumov, Phalguni Ghosh, Yan Jia, Svetlana V Avdulov, Peter S. Dahlberg, Mark Peterson, Karen Smith, Vitaly A Polunovsky, Peter B Bitterman, Carston R Wagner

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Normal growth and development depends upon high fidelity regulation of cap-dependent translation initiation, a process that is usurped and redirected in cancer to mediate acquisition of malignant properties. The epithelial-to-mesenchymal transition (EMT) is a key translationally regulated step in the development of epithelial cancers and pathological tissue fibrosis. To date, no compounds targeting EMT have been developed. Here we report the synthesis of a novel class of histidine triad nucleotide binding protein (HINT)-dependent pronucleotides that interdict EMT by negatively regulating the association of eIF4E with the mRNA cap. Compound eIF4E inhibitor-1 potently inhibited cap-dependent translation in a dose-dependent manner in zebrafish embryos without causing developmental abnormalities and prevented eIF4E from triggering EMT in zebrafish ectoderm explants without toxicity. Metabolism studies with whole cell lysates demonstrated that the prodrug was rapidly converted into 7-BnGMP. Thus we have successfully developed the first nontoxic small molecule able to inhibit EMT, a key process in the development of epithelial cancer and tissue fibrosis, by targeting the interaction of eIF4E with the mRNA cap and demonstrated the tractability of zebrafish as a model organism for studying agents that modulate EMT. Our work provides strong motivation for the continued development of compounds designed to normalize cap-dependent translation as novel chemo-preventive agents and therapeutics for cancer and fibrosis.

Original languageEnglish (US)
Pages (from-to)367-377
Number of pages11
JournalACS Chemical Biology
Volume4
Issue number5
DOIs
StatePublished - May 15 2009

Fingerprint

Epithelial-Mesenchymal Transition
Tissue
Messenger RNA
Prodrugs
Zebrafish
Histidine
Metabolism
Toxicity
Carrier Proteins
Fibrosis
Nucleotides
Association reactions
Molecules
Neoplasms
Ectoderm
Growth and Development
Embryonic Structures
Epithelium

Cite this

Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation. / Ghosh, Brahma; Benyumov, Alexey; Ghosh, Phalguni; Jia, Yan; Avdulov, Svetlana V; Dahlberg, Peter S.; Peterson, Mark; Smith, Karen; Polunovsky, Vitaly A; Bitterman, Peter B; Wagner, Carston R.

In: ACS Chemical Biology, Vol. 4, No. 5, 15.05.2009, p. 367-377.

Research output: Contribution to journalArticle

Ghosh, Brahma ; Benyumov, Alexey ; Ghosh, Phalguni ; Jia, Yan ; Avdulov, Svetlana V ; Dahlberg, Peter S. ; Peterson, Mark ; Smith, Karen ; Polunovsky, Vitaly A ; Bitterman, Peter B ; Wagner, Carston R. / Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation. In: ACS Chemical Biology. 2009 ; Vol. 4, No. 5. pp. 367-377.
@article{1d0b252dd2354ecaa2199cf750edb733,
title = "Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation",
abstract = "Normal growth and development depends upon high fidelity regulation of cap-dependent translation initiation, a process that is usurped and redirected in cancer to mediate acquisition of malignant properties. The epithelial-to-mesenchymal transition (EMT) is a key translationally regulated step in the development of epithelial cancers and pathological tissue fibrosis. To date, no compounds targeting EMT have been developed. Here we report the synthesis of a novel class of histidine triad nucleotide binding protein (HINT)-dependent pronucleotides that interdict EMT by negatively regulating the association of eIF4E with the mRNA cap. Compound eIF4E inhibitor-1 potently inhibited cap-dependent translation in a dose-dependent manner in zebrafish embryos without causing developmental abnormalities and prevented eIF4E from triggering EMT in zebrafish ectoderm explants without toxicity. Metabolism studies with whole cell lysates demonstrated that the prodrug was rapidly converted into 7-BnGMP. Thus we have successfully developed the first nontoxic small molecule able to inhibit EMT, a key process in the development of epithelial cancer and tissue fibrosis, by targeting the interaction of eIF4E with the mRNA cap and demonstrated the tractability of zebrafish as a model organism for studying agents that modulate EMT. Our work provides strong motivation for the continued development of compounds designed to normalize cap-dependent translation as novel chemo-preventive agents and therapeutics for cancer and fibrosis.",
author = "Brahma Ghosh and Alexey Benyumov and Phalguni Ghosh and Yan Jia and Avdulov, {Svetlana V} and Dahlberg, {Peter S.} and Mark Peterson and Karen Smith and Polunovsky, {Vitaly A} and Bitterman, {Peter B} and Wagner, {Carston R}",
year = "2009",
month = "5",
day = "15",
doi = "10.1021/cb9000475",
language = "English (US)",
volume = "4",
pages = "367--377",
journal = "ACS Chemical Biology",
issn = "1554-8929",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Nontoxic chemical interdiction of the epithelial-to-mesenchymal transition by targeting cap-dependent translation

AU - Ghosh, Brahma

AU - Benyumov, Alexey

AU - Ghosh, Phalguni

AU - Jia, Yan

AU - Avdulov, Svetlana V

AU - Dahlberg, Peter S.

AU - Peterson, Mark

AU - Smith, Karen

AU - Polunovsky, Vitaly A

AU - Bitterman, Peter B

AU - Wagner, Carston R

PY - 2009/5/15

Y1 - 2009/5/15

N2 - Normal growth and development depends upon high fidelity regulation of cap-dependent translation initiation, a process that is usurped and redirected in cancer to mediate acquisition of malignant properties. The epithelial-to-mesenchymal transition (EMT) is a key translationally regulated step in the development of epithelial cancers and pathological tissue fibrosis. To date, no compounds targeting EMT have been developed. Here we report the synthesis of a novel class of histidine triad nucleotide binding protein (HINT)-dependent pronucleotides that interdict EMT by negatively regulating the association of eIF4E with the mRNA cap. Compound eIF4E inhibitor-1 potently inhibited cap-dependent translation in a dose-dependent manner in zebrafish embryos without causing developmental abnormalities and prevented eIF4E from triggering EMT in zebrafish ectoderm explants without toxicity. Metabolism studies with whole cell lysates demonstrated that the prodrug was rapidly converted into 7-BnGMP. Thus we have successfully developed the first nontoxic small molecule able to inhibit EMT, a key process in the development of epithelial cancer and tissue fibrosis, by targeting the interaction of eIF4E with the mRNA cap and demonstrated the tractability of zebrafish as a model organism for studying agents that modulate EMT. Our work provides strong motivation for the continued development of compounds designed to normalize cap-dependent translation as novel chemo-preventive agents and therapeutics for cancer and fibrosis.

AB - Normal growth and development depends upon high fidelity regulation of cap-dependent translation initiation, a process that is usurped and redirected in cancer to mediate acquisition of malignant properties. The epithelial-to-mesenchymal transition (EMT) is a key translationally regulated step in the development of epithelial cancers and pathological tissue fibrosis. To date, no compounds targeting EMT have been developed. Here we report the synthesis of a novel class of histidine triad nucleotide binding protein (HINT)-dependent pronucleotides that interdict EMT by negatively regulating the association of eIF4E with the mRNA cap. Compound eIF4E inhibitor-1 potently inhibited cap-dependent translation in a dose-dependent manner in zebrafish embryos without causing developmental abnormalities and prevented eIF4E from triggering EMT in zebrafish ectoderm explants without toxicity. Metabolism studies with whole cell lysates demonstrated that the prodrug was rapidly converted into 7-BnGMP. Thus we have successfully developed the first nontoxic small molecule able to inhibit EMT, a key process in the development of epithelial cancer and tissue fibrosis, by targeting the interaction of eIF4E with the mRNA cap and demonstrated the tractability of zebrafish as a model organism for studying agents that modulate EMT. Our work provides strong motivation for the continued development of compounds designed to normalize cap-dependent translation as novel chemo-preventive agents and therapeutics for cancer and fibrosis.

UR - http://www.scopus.com/inward/record.url?scp=65749084524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65749084524&partnerID=8YFLogxK

U2 - 10.1021/cb9000475

DO - 10.1021/cb9000475

M3 - Article

VL - 4

SP - 367

EP - 377

JO - ACS Chemical Biology

JF - ACS Chemical Biology

SN - 1554-8929

IS - 5

ER -